AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 188 filers reported holding AXSOME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 3.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,981,214 | +12.2% | 56,964 | +15.3% | 1.84% | +13.5% |
| Q2 2023 | $3,549,884 | -5.3% | 49,400 | -18.7% | 1.62% | -46.8% |
| Q1 2023 | $3,748,540 | -11.8% | 60,774 | +10.2% | 3.05% | +21.0% |
| Q4 2022 | $4,251,714 | +464.6% | 55,124 | +226.4% | 2.52% | +487.0% |
| Q3 2022 | $753,000 | +14.1% | 16,886 | +44.8% | 0.43% | -12.2% |
| Q1 2021 | $660,000 | -26.4% | 11,664 | +5.9% | 0.49% | -14.5% |
| Q4 2020 | $897,000 | +109.6% | 11,013 | +83.2% | 0.57% | +83.7% |
| Q3 2020 | $428,000 | -25.0% | 6,012 | -13.4% | 0.31% | -34.0% |
| Q2 2020 | $571,000 | – | 6,941 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |